Followers

0
0
0
0
.
5
5
7
7
9
9
,
4
4
-14.50 (-0.29%)

As on 28 Nov, 2025 | 15:57

Open Trading A/c
Day Range
4,953.50
5,050.50
LH
52 Week Range
3,701.00
5,993.00
LH
Volume
* i
Bid / Ask
62,474.00
0.00 / 0.00

Pfizer Announcements

Pursuant to Regulations 30 and 33 of the Listing Regulations, we submit herewith the Unaudited Financial Results of the Company for the quarter and half...

12 Nov, 2025 | 03:37pm • Source: BSE

Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve...

03 Nov, 2025 | 06:02pm • Source: BSE

Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025.

08 Oct, 2025 | 05:44pm • Source: BSE

We would like to inform you that, for the purpose of declaration of unaudited financial results of the Company for the quarter and half year...

29 Sep, 2025 | 05:40pm • Source: BSE

Unaudited Financial Results for quarter ended June 30, 2025

13 Aug, 2025 | 05:04pm • Source: BSE

Unaudited Financial results for the quarter ended June 30, 2025

13 Aug, 2025 | 04:58pm • Source: BSE

Pfizer Launches 20-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV20) for Adults in India, offering broad protection against Pneumococcal Disease.

11 Aug, 2025 | 07:20pm • Source: BSE

Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015, we hereby inform that Company has announced the launch of its next generation 20-valent Pneumococcal Polysaccharide...

11 Aug, 2025 | 07:06pm • Source: BSE

Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve...

07 Aug, 2025 | 06:00pm • Source: BSE

Please find enclosed proceedings of the 74th Annual General Meeting of the Company held on Monday, July 21, 2025 at 3.00 P.M. IST.

21 Jul, 2025 | 07:23pm • Source: BSE

We furnish herewith certificate confirming compliance with Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter ended June 30, 2025.

07 Jul, 2025 | 07:38pm • Source: BSE

Please find enclosed letter to the shareholders pursuant to Regulation 36(1)(b) of SEBI LODR Regulations, 2015.

30 Jun, 2025 | 09:21pm • Source: BSE

Newspaper Advertisement - Notice of the 74th Annual General Meeting

30 Jun, 2025 | 06:30pm • Source: BSE

Closure of Trading window for the purpose of declaration of Unaudited Financial Results of the Company, for the quarter ending June 30, 2025.

30 Jun, 2025 | 06:10pm • Source: BSE

We submit herewith the Business Responsibility and Sustainability Report for financial year 2024-25. The report also forms part of the Annual Report of FY 2024-25...

29 Jun, 2025 | 10:39pm • Source: BSE

We submit herewith the Annual Report of the Company for Financial Year 2024-25

29 Jun, 2025 | 10:25pm • Source: BSE

Pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we submit herewith notice of the 74th Annual General Meeting scheduled on...

29 Jun, 2025 | 10:18pm • Source: BSE

Annual Secretarial Compliance Report for the financial year ended March 31, 2025

23 May, 2025 | 01:21pm • Source: BSE

Appointment of Cost and Secretarial Auditor

19 May, 2025 | 10:53pm • Source: BSE

Intimation of date of Annual General Meeting

19 May, 2025 | 10:49pm • Source: BSE